NZ188755A - Formulations of steroids of estrane,androstane and 19-nor-pregnane series and tocol or a derivative thereof - Google Patents

Formulations of steroids of estrane,androstane and 19-nor-pregnane series and tocol or a derivative thereof

Info

Publication number
NZ188755A
NZ188755A NZ188755A NZ18875578A NZ188755A NZ 188755 A NZ188755 A NZ 188755A NZ 188755 A NZ188755 A NZ 188755A NZ 18875578 A NZ18875578 A NZ 18875578A NZ 188755 A NZ188755 A NZ 188755A
Authority
NZ
New Zealand
Prior art keywords
estrane
tocol
androstane
steroids
formulations
Prior art date
Application number
NZ188755A
Other languages
English (en)
Inventor
L Cornelius
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of NZ188755A publication Critical patent/NZ188755A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
NZ188755A 1977-10-29 1978-10-27 Formulations of steroids of estrane,androstane and 19-nor-pregnane series and tocol or a derivative thereof NZ188755A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7711916A NL7711916A (nl) 1977-10-29 1977-10-29 Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden.

Publications (1)

Publication Number Publication Date
NZ188755A true NZ188755A (en) 1981-02-11

Family

ID=19829436

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ188755A NZ188755A (en) 1977-10-29 1978-10-27 Formulations of steroids of estrane,androstane and 19-nor-pregnane series and tocol or a derivative thereof

Country Status (10)

Country Link
US (1) US4212863A (enExample)
EP (1) EP0001851B1 (enExample)
JP (1) JPS5480404A (enExample)
AU (1) AU523752B2 (enExample)
CH (1) CH643738A5 (enExample)
DE (1) DE2861320D1 (enExample)
DK (1) DK152721C (enExample)
FI (1) FI67298C (enExample)
NL (1) NL7711916A (enExample)
NZ (1) NZ188755A (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59409873D1 (de) * 1993-04-20 2001-10-25 Hexal Ag Wirkstoffpflaster
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
GB0000313D0 (en) * 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
US6703398B2 (en) * 2001-11-26 2004-03-09 Oliver Yoa-Pu Hu Orally administered analgesic compositions containing nalbuphine
WO2003061566A2 (en) * 2002-01-24 2003-07-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Anti-cancer combination and use thereof
JO2505B1 (en) 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
GB0807605D0 (en) 2008-04-28 2008-06-04 Diurnal Ltd Lipid composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3025311A (en) * 1955-07-01 1962-03-13 Upjohn Co Hydrocortisone 21-beta beta-dimethyl glutarate and derivatives thereof
US2791609A (en) * 1956-09-27 1957-05-07 Murray A Kaplan Tetracycline metallo-phosphate complexes and method preparation
US3085939A (en) * 1959-05-11 1963-04-16 Upjohn Co Oil-in-water emulsion for oral administration, and process for preparation
US3149037A (en) * 1962-09-07 1964-09-15 Hoffmann La Roche Vitamin compositions
DE1492034A1 (de) * 1965-05-18 1969-02-20 Merck Ag E Verfahren zur Herstellung fester haltbarer Zubereitungen von empfindlichen,in Wasser schwer loeslichen Wirkstoffen,vorzugsweise Arzneimitteln
JPS4916422B1 (enExample) * 1966-05-09 1974-04-22
US3636195A (en) * 1968-09-10 1972-01-18 Borden Inc Growth stimulating animal feeds
DE2240187A1 (de) * 1972-08-16 1974-02-21 Jereb Franz Dr Albin Salbe
GB1453239A (en) * 1974-04-30 1976-10-20 Ahrens G W Vitamin e active product and a method of preparing same

Also Published As

Publication number Publication date
US4212863A (en) 1980-07-15
DK152721C (da) 1988-09-26
JPS5480404A (en) 1979-06-27
DK152721B (da) 1988-05-02
DE2861320D1 (en) 1982-01-14
DK480178A (da) 1979-04-30
AU4115878A (en) 1980-05-08
FI783249A7 (fi) 1979-04-30
EP0001851A1 (en) 1979-05-16
FI67298C (fi) 1985-03-11
CH643738A5 (en) 1984-06-29
JPS6341887B2 (enExample) 1988-08-19
NL7711916A (nl) 1979-05-02
EP0001851B1 (en) 1981-11-11
AU523752B2 (en) 1982-08-12
FI67298B (fi) 1984-11-30

Similar Documents

Publication Publication Date Title
AU522854B2 (en) Corticoid 17-(alkyl-carbonates
AU519916B2 (en) 11 beta-substituted steroids
AU518997B2 (en) Steroid cyanoketones
AU516256B2 (en) Photocleable steroids
JPS53141249A (en) Derivative of steroidal*16alph * 17alphaab*naphthaline and its preparation
AU523752B2 (en) Concentrated liquid formulation of steroid and tocol
NZ188038A (en) Di-orthosubstituted benzene derivatives and pharmaceutical compositions
NZ187431A (en) 19-oxygenated pregnane derivatives and pharmaceutical compositions
ZA78969B (en) Solid steroid composition and process for preparation
IL53012A (en) Polyhalogenated steroids of the pregnane series,their manufacture and pharmaceutical compositions containing them
NZ185341A (en) 19-oxygenated steroids and pharmaceutical compositions
AU529292B2 (en) 17-substituted pregnane steroids
IL58778A0 (en) Preparation of steroids of the pregnane series
AU503505B2 (en) 13-ethynyl and 13-halovinyl steroids
JPS5390253A (en) Novel 11betaasurstituted steroid derivative and process for preparing same
JPS53116363A (en) Triterpene derivative and process for preparing same
IL54169A (en) Steroid spirooxazolidines,their preparation and pharmaceutical compositions containing them
AU523556B2 (en) Pregnane derivatives
IE782486L (en) Manufacture of pregnane derivative.
ZA79538B (en) An anti-inflammatory steroid of the androstane series
AU494036B2 (en) novel D-HOMO STEROIDS
NZ186388A (en) A process for the preparation of certain derivatives of isobtyramide: these derivatives when so prepared and therapeutic compositions cotanining them
AU494134B2 (en) 2-aminomethyl-5-hydroxy-4h-pyran-4-one and derivatives thereof
NZ188563A (en) 3a-hydroxy-11a-dialkylamino steroids and pharmaceutical compositions
AU4483979A (en) Derivatives of 4,5-seco estrane 3,5,17-trione